Tag: Emicizumab

In the United States, hemophilia is estimated to affect between 30,000 and 33,000 males [1.9.1]. The question, 'What is the drug of choice for hemophilia?' does not have a single answer, as treatment is highly individualized based on the type, severity, and patient-specific factors.

According to recent medical data, the term 'EMI drug' is not a standard pharmacological classification and can refer to several distinct medications or concepts, leading to significant confusion. The most common interpretations involve specific brand-name medications containing active ingredients like ondansetron or ramipril, as well as the important medical concept of electromagnetic interference (EMI) affecting medical devices. This guide will provide clarity on the different meanings and contexts surrounding the term 'EMI drug'.